Insider trades › Elevance Health › Mark Kaye
Mark Kaye: Elevance Health stock transactions
Mark Kaye (EVP & CFO at Elevance Health) reported 2 transactions in ELV stock on SEC Form 4 over the last 120 days. Name as filed with the SEC: Kaye Mark.
$0open-market sales (0 shares)
$0open-market purchases (0 shares)
2026-10-02most recent transaction
Transactions
| Date | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Oct 2, 2026 | Shares withheld for tax | 4,161 | $386.43 | — | Form 4 ↗ |
| Oct 2, 2026 | Grant or award | 2,627 | — | — | Form 4 ↗ |
Source: SEC EDGAR Form 4 filings; each row links to the filing. Sales marked "10b5-1 plan" were reported as made under a pre-arranged trading plan. Insider trades are reported facts, not recommendations. Not investment advice.